SBIO vs. PDBC
SBIO (ALPS Medical Breakthroughs ETF) and PDBC (Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF) are both exchange-traded funds - SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index, while PDBC is a Commodities fund actively managed by Invesco. SBIO is passively managed, while PDBC is actively managed. Over the past 10 years, SBIO returned 11.79%/yr vs 7.69%/yr for PDBC. At a 0.12 correlation, their price movements are largely independent. SBIO charges 0.50%/yr vs 0.58%/yr for PDBC.
Performance
SBIO vs. PDBC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SBIO achieves a 31.24% return, which is significantly higher than PDBC's 24.08% return. Over the past 10 years, SBIO has outperformed PDBC with an annualized return of 11.79%, while PDBC has yielded a comparatively lower 7.69% annualized return.
SBIO
- 1D
- -2.49%
- 1M
- 27.41%
- 6M
- 30.85%
- YTD
- 31.24%
- 1Y
- 108.24%
- 3Y*
- 30.52%
- 5Y*
- 7.28%
- 10Y*
- 11.79%
PDBC
- 1D
- 0.12%
- 1M
- -3.63%
- 6M
- 21.24%
- YTD
- 24.08%
- 1Y
- 27.16%
- 3Y*
- 9.96%
- 5Y*
- 10.22%
- 10Y*
- 7.69%
SBIO vs. PDBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SBIO ALPS Medical Breakthroughs ETF | 31.24% | 55.07% | 3.81% | 8.68% | -28.08% | -17.55% | 21.17% | 50.30% | -11.81% | 45.67% |
PDBC Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF | 24.08% | 5.96% | 2.09% | -6.25% | 19.23% | 41.72% | -7.84% | 11.44% | -12.78% | 5.06% |
Correlation
The correlation between SBIO and PDBC is -0.21, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.07 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.02 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Dec 31, 2014 | 0.12 |
The correlation between SBIO and PDBC shifts across timeframes, from -0.21 (1 year) to 0.12 (10 years), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SBIO vs. PDBC — Risk / Return Rank
SBIO
PDBC
SBIO vs. PDBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ALPS Medical Breakthroughs ETF (SBIO) and Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF (PDBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SBIO | PDBC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.93 | ||
| Sortino ratioReturn per unit of downside risk | +2.15 | ||
| Omega ratioGain probability vs. loss probability | 1.51 | 1.27 | +0.24 |
| Calmar ratioReturn relative to maximum drawdown | 8.38 | 1.75 | +6.63 |
| Martin ratioReturn relative to average drawdown | 23.39 | 6.25 | +17.14 |
Loading charts...
Drawdowns
SBIO vs. PDBC - Drawdown Comparison
The maximum SBIO drawdown since its inception was -63.06%, which is greater than PDBC's maximum drawdown of -49.52%. Use the drawdown chart below to compare losses from any high point for SBIO and PDBC.
Loading charts...
Drawdown Indicators
| SBIO | PDBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -63.06% | -49.52% | -13.54% |
Max Drawdown (1Y)Largest decline over 1 year | -12.66% | -16.55% | +3.89% |
Max Drawdown (3Y)Largest decline over 3 years | -42.44% | -16.55% | -25.89% |
Max Drawdown (5Y)Largest decline over 5 years | -52.49% | -27.63% | -24.86% |
Max Drawdown (10Y)Largest decline over 10 years | -63.06% | -40.73% | -22.33% |
Current DrawdownCurrent decline from peak | -2.49% | -13.06% | +10.57% |
Average DrawdownAverage peak-to-trough decline | -28.25% | -23.11% | -5.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.53% | 4.64% | -0.11% |
Volatility
SBIO vs. PDBC - Volatility Comparison
ALPS Medical Breakthroughs ETF (SBIO) has a higher volatility of 9.67% compared to Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF (PDBC) at 5.48%. This indicates that SBIO's price experiences larger fluctuations and is considered to be riskier than PDBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SBIO | PDBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.67% | 5.48% | +4.19% |
Volatility (6M)Calculated over the trailing 6-month period | 23.83% | 16.59% | +7.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.48% | 18.72% | +11.76% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 33.86% | 19.19% | +14.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.15% | 17.75% | +15.40% |
SBIO vs. PDBC - Expense Ratio Comparison
SBIO has a 0.50% expense ratio, which is lower than PDBC's 0.58% expense ratio.
Dividends
SBIO vs. PDBC - Dividend Comparison
SBIO has not paid dividends to shareholders, while PDBC's dividend yield for the trailing twelve months is around 3.09%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
PDBC Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF | 3.09% | 3.84% | 4.42% | 4.21% | 13.05% | 50.83% | 0.01% | 1.40% | 1.00% | 3.83% | 6.51% |
SBIO ALPS Medical Breakthroughs ETF | 0.00% | 0.00% | 3.55% | 0.22% | 0.00% | 0.00% | 0.00% | 0.04% | 2.79% | 1.77% | 0.00% |
Frequently Asked Questions
SBIO and PDBC have a correlation of -0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SBIO has higher volatility (9.67%) compared to PDBC (5.48%). In terms of maximum drawdown, SBIO dropped -63.06% vs PDBC's -49.52%.
On 10-year performance, SBIO leads with 11.79% vs 7.69% for PDBC. On fees, SBIO is cheaper at 0.50% per year. On volatility, PDBC has been the lower-risk option at 5.48%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, SBIO has performed better with a 11.79% return vs 7.69%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
SBIO is cheaper with a 0.50% expense ratio, compared with 0.58% for PDBC.
PDBC has the higher dividend yield at 3.09%, compared with 0.00% for SBIO.
SBIO is categorized as Health & Biotech Equities, while PDBC is Commodities. They also come from different issuers: SS&C and Invesco. Their fees differ too: 0.50% for SBIO and 0.58% for PDBC.
SBIO currently has the higher Sharpe Ratio (3.48 vs 1.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SBIO and PDBC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer